ALBUSTIX Trademark

Trademark Overview

On Wednesday, October 24, 2018, a trademark application was filed for ALBUSTIX with the United States Patent and Trademark Office. The USPTO has given the ALBUSTIX trademark a serial number of 88167919. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, November 27, 2025. This trademark is owned by Ascensia Diabetes Care Holdings AG. The ALBUSTIX trademark is filed in the Pharmaceutical Products category with the following description:

Preparation, not for internal use, in the form of medical diagnostic reagents in the form of test strips for testing Albumin in urine
albustix

General Information

Serial Number88167919
Word MarkALBUSTIX
Filing DateWednesday, October 24, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, November 27, 2025
Registration Number5798221
Registration DateTuesday, July 9, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2019

Trademark Statements

Goods and ServicesPreparation, not for internal use, in the form of medical diagnostic reagents in the form of test strips for testing Albumin in urine

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, March 16, 2019
Primary Code005
First Use Anywhere DateFriday, November 9, 1956
First Use In Commerce DateFriday, November 9, 1956

Trademark Owner History

Party NameAscensia Diabetes Care Holdings AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBasel 4052
CH
Party NameAscensia Diabetes Care Holdings AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel 4052
CH
Party NameAscensia Diabetes Care Holdings AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel 4052
CH

Trademark Events

Event DateEvent Description
Saturday, October 27, 2018NEW APPLICATION ENTERED
Wednesday, November 7, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 28, 2018ASSIGNED TO EXAMINER
Thursday, January 3, 2019EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Thursday, January 3, 2019COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Thursday, January 3, 2019EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, January 3, 2019NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, March 12, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 16, 2019ASSIGNED TO LIE
Saturday, March 16, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, March 16, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 19, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 23, 2019PUBLISHED FOR OPPOSITION
Tuesday, April 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2019REGISTERED-PRINCIPAL REGISTER
Friday, December 4, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 4, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 4, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 4, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 9, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 12, 2025TEAS SECTION 8 & 15 RECEIVED
Thursday, November 27, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, November 27, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, November 27, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

albustix form strips testing albumin test urine reagents internal medical diagnostic